Searchable abstracts of presentations at key conferences in endocrinology

ea0081p716 | Thyroid | ECE2022

Antenatal thyroid hormone therapy and antithyroid drug use in Norway from 2004 to 2018

Bakken Kjersti , Nermo Kristina , Gunnar Nedrebo Bjorn , IM Korevaar Tim , Strand Tor A.

Thyroid disease during pregnancy is associated with adverse pregnancy outcomes and suboptimal fetal development. During the last decades, guidelines for diagnosing thyroid disease during pregnancy have changed considerably, and there has been increased awareness. This study aimed to describe the prevalence of thyroid disease treatment over time among pregnant women in Norway. We combined historical data from the Medical Birth Registry of Norway and the Norwegian Prescription D...

ea0081ep503 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Inadequate iodine intake in lactating women in the inland area of norway

Aarsland Tonje Eiane , Kaldenbach Siri , Solvik Beate Stokke , Bakken Kjersti S. , Strand Tor Arne

Background: Many studies in Norway have found inadequate iodine status in pregnant and lactating women, but no studies have been undertaken in a random, population-based sample. Globally, the main strategy to eliminate iodine deficiency is iodization of salt. However, this is not compulsory in Norway, where the current legislation only permits iodization up to 5 μg per gram of salt. To reach the Nordic Nutrition Recommendation (NNR) of 200 μg/day iodine, supplements ...

ea0007p16 | Comparative endocrinology | BES2004

Developmental changes in gonadal and adrenal steroidogenesis in the blue fox (Alopex lagopus)

Osadchuk L , Braastad B , Hovland A , Bakken M

At present, the blue fox is extensively studied in connection with the process of domestication and there is a need for a better understanding of endocrine processes associated with reproductive and stress-response development in this species. Plasma concentrations of testosterone, oestradiol, ACTH and cortisol, gonadal in vitro production of testosterone and oestradiol and adrenal in vitro production of cortisol were measured by RIA in foetal (47-48 days of pregnancy, n=69), ...

ea0049ep33 | Adrenal cortex (to include Cushing's) | ECE2017

Rapid reduction in left ventricular mass in primary aldosteronism after treatment; a prospective cardiac MRI study

Grytaas Marianne Aardal , Sellevag Kjersti , Thordarson Hrafnkell Baldur , Husebye Eystein Sverre , Lovas Kristian , Larsen Terje Hjalmar

Background: Primary aldosteronism (PA) patients have increased left ventricular mass (LVM) and increased cardiovascular morbidity compared with those with essential hypertension. Echocardiographic studies have demonstrated that adrenalectomy or spironolactone decreases LVM. The aim of the present study was to use MRI to assess both LVM and cardiac function before and during stress testing, at baseline and after treatment with adrenalectomy or spironolactone, compared with heal...

ea0041ep856 | Pituitary - Basic | ECE2016

Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas

Normann Kjersti R , Oystese Kristin Astrid Berland , Berg Jens Petter , Bollerslev Jens , Olarescu Nicoleta Cristina

Background: Real-time reverse transcription quantitative PCR (RT-qPCR) has become the method of choice for quantification of gene expression changes. Inappropriate data normalization and inconsistent data analyses are some limitations of RT-qPCR. Pituitary adenomas are frequent tumours and the interpretation of increasingly published data within this field is hindered by the lack of a proper selection and validation of stably expressed reference genes.Ai...

ea0037ep766 | Pituitary: clinical | ECE2015

The metabolic relevance of angiopoietin-like protein 4 in different states of GH/IGF1 excess or deficiency

Olarescu Nicoleta Cristina , Jorgensen Anders P , Heck Ansgar , Normann Kjersti R , Godang Kristin , Bollerslev Jens

Context: Angiopoietin-like protein 4 (Angptl4) is a protein involved in lipolysis, that is regulated by non-esterified free fatty acids (FFA). GH promotes lipolysis and increases circulating FFA. Hypothesis: GH increases circulating Angptl4 levels by modulating its expression and secretion from fat and muscle. Angptl4 might be of metabolic relevance for the insulin resistance associated with GH/IGF1 excess or deficiency.Objective: To evaluate Angptl4 in ...

ea0063gp154 | Cushing's | ECE2019

Pathway enrichment analysis in functioning and silent corticotroph pituitary adenomas reveals mechanisms to explain their distinct clinical behaviour

Olarescu Nicoleta Cristina , Normann Kjersti Ringvoll , Sundaram Arvind YM , Oystese Kristin Astrid Berland , Eieland Alexander , Lekva Tove , Bollerslev Jens

Background: Functioning (FCA) and silent corticotroph (SCA) pituitary adenomas act differently from a clinical perspective, despite both subtypes showing positive ACTH staining by immunohistochemistry. They are challenging to treat, the former due to functional ACTH production and consequently hypercortisolemia leading to Cushing disease, whereas the latter due to invasive and recurrent behaviour. Moreover, the molecular mechanisms behind their distinct behaviour are not clear...

ea0056p783 | Pituitary - Basic | ECE2018

Corticotroph pituitary adenomas: the functioning vs the silent: a gene expression study comparing differentially expressed genes in the regulation of POMC

Normann Kjersti Ringvoll , Sundaram Arvind , Oystese Kristin Astrid Berland , Lekva Tove , Eieland Alexander , Bollerslev Jens , Olarescu Nicoleta Cristina

Background: The exact mechanism behind the hypersecretion of ACTH and lack of negative cortisol feedback on POMC regulation in functional corticotroph adenomas (FCA) is unknown. Silent corticotroph adenomas (SCA) express, but do not secrete functional ACTH and have lower POMC expression. Using RT-qPCR and immunohistochemistry, previous studies have identified some POMC-transcription factors, regulators and processing enzymes to be differentially expressed between FCA and SCA. ...

ea0063gp111 | Calcium and Bone 2 | ECE2019

Hip structure analyses in acromegaly: Decrease of cortical bone thickness after treatment

Godang Kristin , Lekva Tove , Normann Kjersti R , Olarescu Nicoleta Cristina , Oystese Kristin AB , Kolnes Anders , Ueland Thor , Bollerslev Jens , Heck Ansgar

Background: Long standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry including increased cortical bone thickness (CBT). However, a high prevalence and incidence of vertebral fractures has been reported. The aim of this study was to assess the course of cortical bone dimensions in the hip by comparing patients with acromegaly and clinically non-functioning pituitary adenomas (NFPA) at baseline and one year a...

ea0049oc8.3 | Neuroendocrinology | ECE2017

RNA sequencing and RT-qPCR identify different gene expression profiles in fast- vs. slow-growing non-functioning pituitary adenomas

Falch Camilla Maria , Sundaram Arvind Y.M. , Oystese Kristin Astrid Berland , Normann Kjersti Ringvoll , Silamikelis Ivars , Andersen Marianne , Bollerslev Jens , Olarescu Nicoleta Cristina

Background: Non-functioning pituitary adenomas (NFPAs) necessitate prolonged clinical, biochemical and radiological observation, constituting a significant burden in terms of medical resources and societal costs. Reliable biomarkers associated with aggressiveness and recurrence of NFPAs are lacking. As the growth of tumor remnants is highly variable, molecular markers that can predict growth potential and tumor behavior are necessary.Aim: To identify tar...